Vasopressin Receptor 2 Modulators for the Treatment of Related Disorders

Abstract This patent describes compounds that function as vasopressin receptor 2 (V2R) modulators, along with related pharmaceutical compositions, for the treatment of diseases or disorders, including kidney disorders.

Authors

Steven H. Liang (ORCID: https://orcid.org/0000-0003-1413-6315)
Lingxin Meng (ORCID: https://orcid.org/0009-0003-0745-0303)

Institutions

Georgia Institute of Technology (US)
Emory University (US)

Publication Details

Journal: ACS Medicinal Chemistry Letters
Published: 2026-10-05
DOI: https://doi.org/10.1021/acsmedchemlett.6c00501
Primary Topic: Electrolyte and hormonal disorders
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Vasopressin Receptor 2 Modulators for the Treatment of Related Disorders

Steven H. Liang, Lingxin Meng

Oct 5, 2026

ACS Medicinal Chemistry Letters

Electrolyte and hormonal disorders

article

Vasopressin Receptor 2 Modulators for the Treatment of Related Disorders

Steven H. Liang, Lingxin Meng

October 5, 2026article en

Abstract

ACS Medicinal Chemistry Letters

Georgia Institute of Technology (US), Emory University (US)

Openalex Percentile: Top 11%

Electrolyte and hormonal disorders

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Vasopressin Receptor 2 Modulators for the Treatment of Related Disorders — Steven H. Liang, Lingxin Meng · ACS Medicinal Chemistry Letters (2026) | TGRS Research Map | TGRS